- Home
- WTBA vs NGNE Comparison
WTBA vs NGNE Comparison
Compare WTBA & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTBA
- NGNE
- Stock Information
- Founded
- WTBA 1893
- NGNE 2003
- Country
- WTBA United States
- NGNE United States
- Employees
- WTBA N/A
- NGNE N/A
- Industry
- WTBA Major Banks
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- WTBA Finance
- NGNE Health Care
- Exchange
- WTBA Nasdaq
- NGNE Nasdaq
- Market Cap
- WTBA 332.5M
- NGNE 325.3M
- IPO Year
- WTBA N/A
- NGNE N/A
- Fundamental
- Price
- WTBA $19.96
- NGNE $18.48
- Analyst Decision
- WTBA Hold
- NGNE Strong Buy
- Analyst Count
- WTBA 2
- NGNE 7
- Target Price
- WTBA $21.75
- NGNE $41.86
- AVG Volume (30 Days)
- WTBA 33.3K
- NGNE 110.1K
- Earning Date
- WTBA 10-23-2025
- NGNE 08-11-2025
- Dividend Yield
- WTBA 5.01%
- NGNE N/A
- EPS Growth
- WTBA 33.79
- NGNE N/A
- EPS
- WTBA 1.70
- NGNE N/A
- Revenue
- WTBA $87,098,000.00
- NGNE N/A
- Revenue This Year
- WTBA $24.40
- NGNE N/A
- Revenue Next Year
- WTBA $9.68
- NGNE N/A
- P/E Ratio
- WTBA $11.74
- NGNE N/A
- Revenue Growth
- WTBA 15.15
- NGNE N/A
- 52 Week Low
- WTBA $17.31
- NGNE $6.88
- 52 Week High
- WTBA $24.85
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- WTBA 60.68
- NGNE 35.93
- Support Level
- WTBA $19.72
- NGNE $19.59
- Resistance Level
- WTBA $20.13
- NGNE $20.46
- Average True Range (ATR)
- WTBA 0.51
- NGNE 1.23
- MACD
- WTBA 0.19
- NGNE -0.20
- Stochastic Oscillator
- WTBA 92.77
- NGNE 13.37
About WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.